Faculty Opinions recommendation of Congenital heart disease infant death rates decrease as gestational age advances from 34 to 40 weeks.

2011 ◽  
Author(s):  
Lena Sun
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Gestational Age ◽  
Infant Death ◽  
Congenital Heart ◽  
Death Rates

Congenital Heart Disease Infant Death Rates Decrease as Gestational Age Advances from 34 to 40 Weeks

2011 ◽  
Vol 159 (5) ◽  
pp. 761-765 ◽  
Author(s):  
James F. Cnota ◽  
Resmi Gupta ◽  
Erik C. Michelfelder ◽  
Richard F. Ittenbach
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Gestational Age ◽  
Infant Death ◽  
Congenital Heart ◽  
Death Rates

Prolonged Prostaglandin E1 Infusion in an Infant With Cyanotic Congenital Heart Disease

PEDIATRICS ◽  
1978 ◽  
Vol 61 (4) ◽  
pp. 534-536
Author(s):  
Alan B. Lewis ◽  
Paul R. Lurie
Keyword(s):  
Congenital Heart Disease ◽  
Blood Flow ◽  
Heart Disease ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Pulmonary Blood Flow ◽  
Congenital Heart ◽  
Prostaglandin E1 ◽  
Ductus Arteriosus ◽  
Cyanotic Congenital Heart Disease

A small-for-gestational-age premature infant with severe tetralogy of Fallot was treated with prostaglandin E1 to dialate the ductus arteriosus and increase pulmonary blood flow. The infusion was continued for 29 days without complication at which time surgery was performed.

Congenital Heart Disease in non-Diabetic Large-for-Gestational-Age (LGA) Neonates

2020 ◽  
Vol 20 ◽  
Author(s):  
Majid Firouzi ◽  
Hamidreza Sherkatolabbasieh ◽  
Alireza Nezami ◽  
Shiva Shafizadeh
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Birth Weight ◽  
Gestational Age ◽  
Congenital Heart ◽  
Heart Diseases ◽  
Large For Gestational Age ◽  
Congenital Heart Diseases ◽  
Increased Risk ◽  
Heart Abnormalities

Background: Congenital heart diseases are the most prevalent congenital abnormalities in the neonates, caused by the environmental and genetic factors and contribute to the leading cause of death. The aim of this study is to evaluate the relationship between neonates with large for gestational age and increased risk of congenital heart diseases among nondiabetic mothers. Methods: In this study, 179 neonates with large for gestational age in Khorramabad were enrolled where heart abnormalities were evaluated using echocardiography. Results: 87 neonates had more than 4000 g of the birth weight with no heart abnormalities and 92 (51%) macrosomic neonates had congenital heart diseases. Statistical analysis revealed that there was a significant relationship between birth weight and increased risk of acquiring congenital heart disease between the two groups. There was no significant relationship between birth weight, maternal age, gender, labor type and blood group between the two groups. The highest incidence of congenital heart anomalies was related to 38% of arterial septal defect (ASD) and 15.2% of ASD and VSD, respectively Conclusion: The most prevalent abnormality was arterial septal ASD. None of these abnormalities were associated with maternal age, birth weight and neonate gender. Future studies for congenital heart disease and neonatal birth weight are therefore, recommended.

scholarly journals Amplitude-Integrated Electroencephalography: Classification and Possibilities of Use in Practice

2015 ◽  
Vol 5 (1) ◽  
pp. 27-35
Author(s):  
Z. Zimova ◽  
K. Matasova ◽  
M. Zibolen
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Preterm Infants ◽  
Gestational Age ◽  
Congenital Heart ◽  
Hypoxic Ischemic Encephalopathy ◽  
Normative Values ◽  
Term Neonates ◽  
Ischemic Encephalopathy

Abstract Amplitude-integrated electroencephalography (aEEG) is a simplified bedside neurophysiology tool that has become widely used in neonates in the last few years. Although aEEG cannot replace conventional EEG (cEEG) for background monitoring and detection of seizures, it remains a useful apparatus that complements conventional EEG, is being widely adopted by neonatologists, and should be supported by neonatal neurologists. Limited channel leads are applied to the patient and data are displayed in a semilogarithmic, time-compressed scale. In term neonates, aEEG has been used to determine the prognosis and treatment for those affected by hypoxic-ischemic encephalopathy, seizures, meningitis and even congenital heart disease. In preterm infants, normative values and pattern corresponding to gestational age are being established. The senzitivity and specificity of aEEG are enhanced by the display of a simultaneous raw EEG.

scholarly journals Electrocardiographic intervals in foetuses with CHD

2015 ◽  
Vol 26 (1) ◽  
pp. 84-89 ◽  
Author(s):  
Betul Yilmaz ◽  
Hari K. Narayan ◽  
Abigail Wilpers ◽  
Christina Wiess ◽  
William P. Fifer ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Gestational Age ◽  
Congenital Heart ◽  
Heart Diseases ◽  
Qt Intervals ◽  
Observational Cohort ◽  
Student’S T ◽  
Electrocardiographic Intervals ◽  
The Relationship

AbstractObjectivesTo assess foetal electrocardiographic intervals across gestational age among foetuses with and without congenital heart disease, and to investigate differences between groups.DesignA prospective observational cohort study.SettingCenter for Prenatal Pediatrics, Morgan Stanley Children’s Hospital of NewYork-Presbyterian.Population or sampleA total of 92 participants with singleton pregnancies, 41 with normal anatomy and 51 with congenital heart disease were included in this study.MethodsUsing a maternal abdominal monitor, foetal electrocardiogram was obtained serially from foetuses with and without congenital heart disease at 20–24 weeks (F1), 28–32 weeks (F2), and 34–38 weeks (F3) of gestation. A signal-averaged waveform was calculated, and PR, QRS, and QT intervals were measured. Intervals from controls were compared with gestational age norms. Using Pearson’s correlation coefficient, we analysed the relationship between gestational age and foetal electrocardiographic intervals. Intervals from control and congenital heart disease foetuses were compared by Student’s t-test.ResultsPR (r=0.333, p=0.02) and QRS (r=0.248, p=0.05) intervals correlated with gestational age only among controls. QRS intervals in foetuses with congenital heart disease were significantly longer than controls at F1 (63±6 versus 52±5 ms, p<0.001), F2 (61±8 versus 56±7 ms, p=0.02), and F3 (64±10 versus 56±9 ms, p=0.007).ConclusionsPR and QRS intervals lengthen across gestational age among foetuses with normal cardiac anatomy but not in foetuses with congenital heart diseases. As early as 20 weeks of gestation, differences between foetuses with and without congenital heart disease are discernible, with congenital heart disease foetuses demonstrating longer QRS intervals compared with controls.

The association between congenital heart disease and small for gestational age with regard to the prevalence and outcomes

2020 ◽  
Author(s):  
Takamichi Ishikawa ◽  
Hiroki Uchiyama ◽  
Toru Baba ◽  
Akira Ohishi ◽  
Shigeo Iijima ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Congenital Heart

scholarly journals The importance of small for gestational age in the risk assessment of infants with critical congenital heart disease

2013 ◽  
Vol 23 (6) ◽  
pp. 896-904 ◽  
Author(s):  
Anthony A. Sochet ◽  
Mark Ayers ◽  
Emilio Quezada ◽  
Katherine Braley ◽  
Jennifer Leshko ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Congenital Heart ◽  
Surgical Intervention ◽  
Critical Congenital Heart Disease ◽  
Foetal Growth Restriction ◽  
Increased Risk ◽  
Appropriate For Gestational Age

AbstractBackgroundInfants with critical congenital heart disease who require cardiothoracic surgical intervention may have significant post-operative mortality and morbidity. Infants who are small for gestational age <10th percentile with foetal growth restriction may have end-organ dysfunction that may predispose them to increased morbidity or mortality.MethodsA single-institution retrospective review was performed in 230 infants with congenital heart disease who had cardiothoracic surgical intervention <60 days of age. Pre-, peri-, and post-operative morbidity and mortality markers were collected along with demographics and anthropometric measurements.ResultsThere were 230 infants, 57 (23.3%) small for gestational age and 173 (70.6%) appropriate for gestational age. No significant difference was noted in pre-operative markers – gestational age, age at surgery, corrected gestational age, Society for Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality score; or post-operative factors – length of stay, ventilation days, arrhythmias, need for extracorporeal membrane oxygenation, vocal cord dysfunction, hearing loss; or end-organ dysfunction – gastro-intestinal, renal, central nervous system, or genetic. Small for gestational age infants were more likely to have failed vision tests (p = 0.006). Small for gestational age infants were more likely to have increased 30-day (p = 0.005) and discharge mortality (p = 0.035). Small for gestational age infants with normal birth weight (>2500 g) were also at increased risk of 30-day mortality compared with appropriate for gestational age infants (p = 0.045).ConclusionsSmall for gestational age infants with congenital heart disease who undergo cardiothoracic surgery <60 days of age have increased risk of mortality and failed vision screening. Assessment of foetal growth restriction as part of routine pre-operative screening may be beneficial.

Sign in / Sign up

Export Citation Format

Share Document